We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+16.76%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$25.6B
AUM Growth
+$2.65B
(+12%)
Cap. Flow
-$1.17B
Cap. Flow
% of AUM
-4.57%
Top 10 Holdings %
Top 10 Hldgs %
14.38%
Holding
1,445
New
151
Increased
481
Reduced
509
Closed
137
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$56.6M |
| 2 |
Fidelity National Information Services
FIS
|
+$53M |
| 3 |
Advanced Micro Devices
AMD
|
+$48.1M |
| 4 |
RTX Corp
RTX
|
+$43.3M |
| 5 |
Analog Devices
ADI
|
+$38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$72.1M |
| 2 |
PepsiCo
PEP
|
+$70.8M |
| 3 |
American Express
AXP
|
+$70.7M |
| 4 |
Automatic Data Processing
ADP
|
+$49.7M |
| 5 |
Synchrony
SYF
|
+$47.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.67% |
| 2 | Healthcare | 15.33% |
| 3 | Consumer Discretionary | 10% |
| 4 | Financials | 9.76% |
| 5 | Industrials | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Rocket Pharmaceuticals
RCKT
$380M
| $3.68M | 0.01% |
209,684
+47,856
| +30% | +$756K |
|
702
Bank OZK
OZK
$5.35B
| $3.67M | 0.01% |
126,825
+1,973
| +2% | +$59.7K |
|
703
Tyler Technologies
TYL
$14.3B
| $3.67M | 0.01% |
17,955
-110
| -0.6% | -$21.8K |
|
|
CTRA
704
DELISTED
Coterra Energy
CTRA
| $3.66M | 0.01% |
140,202
+128,462
| +1,094% | +$3.22M |
|
705
Paycom
PAYC
$10.3B
| $3.65M | 0.01% |
19,300
+800
| +4% | +$130K |
|
706
AES
AES
$10.6B
| $3.64M | 0.01% |
201,300
-304,766
| -60% | -$5.12M |
|
|
ULTI
707
DELISTED
Ultimate Software Group Inc
ULTI
| $3.61M | 0.01% |
10,945
-111,046
| -91% | -$34M |
|
|
CSR
708
Centerspace
CSR
$970M
| $3.6M | 0.01% |
60,150
+13,570
| +29% | +$789K |
|
709
Ollie's Bargain Outlet
OLLI
$4.55B
| $3.6M | 0.01% |
42,155
| – | – |
|
710
Aclaris Therapeutics
ACRS
$752M
| $3.58M | 0.01% |
598,160
+216,212
| +57% | +$1.43M |
|
711
Edgewell Personal Care
EPC
$1.24B
| $3.58M | 0.01% |
+81,600
| New | +$3.4M |
|
712
Strategy Inc
MSTR
$50B
| $3.56M | 0.01% |
247,000
+33,000
| +15% | +$457K |
|
|
FLIR
713
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $3.54M | 0.01% |
74,487
-393
| -0.5% | -$19K |
|
|
ORBC
714
DELISTED
ORBCOMM, Inc.
ORBC
| $3.54M | 0.01% |
521,929
-902
| -0.2% | -$7.21K |
|
715
Franco-Nevada
FNV
$50.6B
| $3.53M | 0.01% |
47,074
+4,648
| +11% | +$345K |
|
716
Independence Realty Trust
IRT
$3.57B
| $3.52M | 0.01% |
326,000
+260,800
| +400% | +$2.68M |
|
|
MTEM
717
DELISTED
Molecular Templates, Inc.
MTEM
| $3.49M | 0.01% |
40,000
| – | – |
|
718
Invesco S&P MidCap Low Volatility ETF
XMLV
$727M
| $3.47M | 0.01% |
69,930
+4,190
| +6% | +$201K |
|
|
CONE
719
DELISTED
CyrusOne Inc Common Stock
CONE
| $3.46M | 0.01% |
66,001
-94,405
| -59% | -$4.94M |
|
|
REGI
720
DELISTED
Renewable Energy Group, Inc.
REGI
| $3.45M | 0.01% |
157,173
-3,800
| -2% | -$97.9K |
|
|
TYPE
721
DELISTED
Monotype Imaging Holdings Inc.
TYPE
| $3.45M | 0.01% |
173,300
+140,400
| +427% | +$2.53M |
|
722
Silicon Motion
SIMO
$8.17B
| $3.43M | 0.01% |
86,582
| – | – |
|
|
DBV
723
DELISTED
Invesco DB G10 Currency Harvest Fund
DBV
| $3.43M | 0.01% |
140,120
| – | – |
|
724
Keysight
KEYS
$55B
| $3.41M | 0.01% |
39,147
-224,082
| -85% | -$17.4M |
|
725
Myriad Genetics
MYGN
$384M
| $3.41M | 0.01% |
102,787
+17,100
| +20% | +$521K |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q1 2019 Portfolio in Review
As of Q1 2019, Axa held 1,445 positions worth $25.6B, up 12% from $22.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Axa withdrew a net $1.17B in Q1 2019, closing 137 positions and reducing 509 holdings. Its most notable exit was Newfield Exploration, an estimated $15.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Axa opened a new position in BlackBerry worth $40.1M.
- Axa's largest Q1 2019 buy was BlackBerry: 3,971,844 shares worth $40.1M.
- Axa added most to Gilead Sciences in Q1 2019, an estimated $56.6M increase.
- Axa's biggest Q1 2019 reduction was Humana, cutting an estimated $72.1M.
- Axa fully exited Newfield Exploration in Q1 2019, selling an estimated $15.3M.
- Axa's ten largest holdings make up 14% of its $25.6B portfolio in Q1 2019.
- Axa opened 151 new positions and closed 137 in Q1 2019.
- Axa's portfolio value rose 12% quarter-over-quarter to $25.6B.
Based on Axa's 13F filing for Q1 2019, filed 14 May 2019.